Urgent.News

One page, thousands of outlets. See who else covered it.

Editions

Business

Henlius partners with Sandoz for 10 biosimilar antibodies

Biotechnology company Henlius entered a strategic collaboration with Sandoz on 17 August 2026 covering up to 10 proposed monoclonal antibody biosimilars for global distribution

We haven't written up this one. Vietnam Investment Review has the full story — the link below goes straight to it.

Read the original at vir.com.vn →

More in Business

More from Tuesday 18 August →